Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000192307 | SCV001390412 | pathogenic | Mucolipidosis type IV | 2021-06-03 | criteria provided, single submitter | clinical testing | Loss-of-function variants in MCOLN1 are known to be pathogenic (PMID: 11030752, 11317355). For these reasons, this variant has been classified as Pathogenic. This variant has been observed in combination with another MCOLN1 variant in an individual affected with mucolipidosis type IV (PMID: 11030752). This variant is known as c.1334_1335insT in the literature. ClinVar contains an entry for this variant (Variation ID: 208028). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr404Leufs*59) in the MCOLN1 gene. It is expected to result in an absent or disrupted protein product. |
Fulgent Genetics, |
RCV005025308 | SCV005648826 | likely pathogenic | Mucolipidosis type IV; Lisch epithelial corneal dystrophy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000192307 | SCV002091404 | pathogenic | Mucolipidosis type IV | 2017-03-17 | no assertion criteria provided | clinical testing |